These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 9074572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
    Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B.
    Lancet; 2000 May 06; 355(9215):1582-7. PubMed ID: 10821361
    [Abstract] [Full Text] [Related]

  • 4. Losartan versus captopril in elderly patients with heart failure.
    Sechi LA, Catena C, Bartoli E.
    Lancet; 1997 May 17; 349(9063):1474; author reply 1475. PubMed ID: 9164337
    [No Abstract] [Full Text] [Related]

  • 5. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group.
    Lancet; 2002 Sep 07; 360(9335):752-60. PubMed ID: 12241832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Losartan versus captopril in elderly patients with heart failure.
    Jensen BV, Nielsen SL.
    Lancet; 1997 May 17; 349(9063):1473; author reply 1475. PubMed ID: 9164335
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K, Chang P, Willenheimer R, Haunsø S, Remes J, Hall C, Kjekshus J.
    J Am Coll Cardiol; 1995 Aug 17; 26(2):438-45. PubMed ID: 7608448
    [Abstract] [Full Text] [Related]

  • 11. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
    Cowley AJ, Wiens BL, Segal R, Rich MW, Santanello NC, Dasbach EJ, Pitt B, ELITE Investigators. Evaluation of Losartan in the Elderly.
    Qual Life Res; 2000 Aug 17; 9(4):377-84. PubMed ID: 11131930
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival after myocardial infarction in rats: captopril versus losartan.
    Milavetz JJ, Raya TE, Johnson CS, Morkin E, Goldman S.
    J Am Coll Cardiol; 1996 Mar 01; 27(3):714-9. PubMed ID: 8606287
    [Abstract] [Full Text] [Related]

  • 14. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA, Neaton JD, Poole-Wilson PA, Pitt B, Segal R, Sharma D, Dasbach EJ, Carides GW, Dickstein K, Riegger G, Camm AJ, Martinez FA, Bradstreet DC, Ikeda LS, Santoro EP, ELITE II Investigators.
    Am Heart J; 2005 Jul 01; 150(1):123-31. PubMed ID: 16084158
    [Abstract] [Full Text] [Related]

  • 15. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA, Patten RD, Thomas I, Ramahi T, La Bresh K, Goldman S, Lewis W, Gradman A, Self KS, Bittner V, Rand W, Kinan D, Smith JJ, Ford T, Segal R, Udelson JE.
    Am Heart J; 2000 Jun 01; 139(6):1081-7. PubMed ID: 10827391
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI, Dunlay MC, Sweet CS.
    Am J Cardiol; 1995 Apr 15; 75(12):793-5. PubMed ID: 7717281
    [Abstract] [Full Text] [Related]

  • 17. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
    Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Valsartan in Acute Myocardial Infarction Trial Investigators.
    N Engl J Med; 2003 Nov 13; 349(20):1893-906. PubMed ID: 14610160
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI.
    J Am Coll Cardiol; 1997 Oct 13; 30(4):983-91. PubMed ID: 9316528
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR, Harrison M, Cowley AJ.
    Eur J Heart Fail; 1999 Dec 13; 1(4):385-93. PubMed ID: 10937952
    [Abstract] [Full Text] [Related]

  • 20. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
    Lynch JJ, Stump GL, Wallace AA, Painter CA, Thomas JM, Kusma SE, Gould RJ, Grossman W.
    J Am Coll Cardiol; 1999 Sep 13; 34(3):876-84. PubMed ID: 10483973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.